Rehabilitation Intervention for COPD Combined With Cardiovascular and Cerebrovascular Diseases
Recruiting · NCT07090200 · Interventional (participants receive a specific treatment) · Lead sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
View the official record on ClinicalTrials.gov →Interventions studied
Pulmonary Rehabilitation Care GroupThe Routine Care (Non-Pharmacological and Pharmacological Treatments ) Group
What this trial is about
Firstly, to screen out the high-risk population of COPD combined with cardiovascular and cerebrovascular diseases, COPD with cardiovascular and make a diagnosis. Then, to evaluate the therapeutic effect of Pulmonary rehabilitation exercise and usual care for three months. And finally, to build a trinity model of rehabilitation management of COPD patients. The objective of this project is to establish and promote the application of diagnostic and treatment norms.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Committed to adhering to the study protocol and cooperating with the implementation of the entire research process.
- Aged 18 years or older, regardless of gender.
- Signed informed consent form.
Exclusion criteria
- Individuals with severe mental illness.
- Individuals assessed by medical personnel as having a disease that requires immediate hospitalization or a severe, uncontrollable condition that is life-threatening in the short term.
- Women who are pregnant, breastfeeding, or using inappropriate contraception methods.
- Individuals who refuse to cooperate with follow-up questionnaires or specimen collection.
- Patients currently participating in other interventional clinical drug trials.
Where it is running
1 location listed.
- Union hospital, Tongji Medical college, Huazhong University of Science and Technology - Wuhan, Hubei, China